The pathological effect on the central nervous system of mice following single and repeated infections of the demyelinating A7(74) strain of Semliki Forest virus.
The avirulent strain A7(74) of Semliki Forest virus was inoculated intraperitoneally into mice at weekly intervals for 7 weeks. Pathological, virological and serological studies were carried out twice weekly, after each infecting dose. Similar studies were performed on mice that had been given repeated inoculations at 2, 3 or 4 weekly intervals as were a group of control mice given a single dose of SFV. Results showed grossly enhanced central nervous system lesions, in particular the perivascular cuffing and demyelination, after the 2nd and 3rd weekly inoculation. With further injections there was no increase in severity of the lesions and by the eighth inoculation the pathological changes in the brain appeared to have recovered. The maximum and most persistent damage to the brain was seen after the 2nd and 3rd weekly inoculations. As the interval between two SFV inoculations was increased, the lesions in the central nervous system were reduced and protection increased. Virus in the blood was only detectable after the first inoculation and brain virus after the first and second inoculations. Peak IgG antibody levels were seen on day 46 after a single inoculation and day 35 in the multiple inoculations. It was concluded that repeated inoculations of SFV do not produce a relapsing demyelinating disease, but the 7th and 14th day inoculations do enhance the lesions which are seen to persist after the inoculation on the 21st day. In spite of the gross pathological changes inflicted, the brain damage appears to recover.
Illavia
S J
SJ
Neurovirology Research Unit, St Thomas' Hospital, United Medical School of Guy's Hospital, London.
Webb
H E
HE
D000818:Animals; D001927:Brain Diseases / Q000382:microbiology / Q000473:pathology*; D003711:Demyelinating Diseases / Q000382:microbiology / Q000473:pathology*; D051379:Mice; D012672:Semliki forest virus / Q000302:isolation & purification; D014036:Togaviridae Infections / Q000473:pathology*